Steven Sangha
Directeur/Membre du Conseil chez BLOCKCHAINK2 CORP.
Fortune : 6 M $ au 30/04/2024
Provenance du réseau au premier degré de Steven Sangha
Entité | Type d'entité | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 15 | |
Public Company | Pharmaceuticals: Major | 9 | |
Public Company | Data Processing Services | 7 | |
Public Company | Precious Metals | 4 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Steven Sangha via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
inVentiv Health Clinical, Inc.
inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
ONCOLYTICS BIOTECH INC. | Biotechnology | Director/Board Member Director/Board Member | |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Medical Specialties | Chief Tech/Sci/R&D Officer Director/Board Member | |
TEARLAB CORPORATION | Medical Specialties | Corporate Officer/Principal | |
Celmatix, Inc.
Celmatix, Inc. Pharmaceuticals: MajorHealth Technology Celmatix, Inc. operates as a personalized medicine company that focuses on women?s health. It offers POLARIS, a web-based analytics platform for optimizing a woman?s fertility; and NOVA, a patient portal that helps clinics to maximize the patient experience. Its products help women to make informed decisions about their fertility, as well as provide doctors with data-driven tools for patient care. The company was founded by Piraye Yurttas Beim and Laura Towart Bandak in 2009 and is headquartered New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
University of Freiburg | College/University | Doctorate Degree | |
Polar Capital LLP
Polar Capital LLP Investment ManagersFinance Polar Capital LLP is an alternative investment manager headquartered in London, UK. The firm is a subsidiary of Polar Capital Partners Ltd., itself a subsidiary of Polar Capital Holdings, Plc (LON: POLR) in Great Britain. Founded in 2001, Polar Capital offers its services primarily to Polar Funds and managed accounts, all of which are pooled investment vehicles. Investors in Polar Funds include individuals, banking or thrift institutions, investment companies (including mutual funds), pension and profit-sharing plans, pooled investment vehicles (such as hedge funds), high net-worth individuals, collateralized debt obligations (CDO’s), charitable organizations, trusts and estates, corporations and other business entities, and state or municipal government entities. | Investment Managers | Consultant / Advisor | |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Grant Thornton LLP
Grant Thornton LLP Miscellaneous Commercial ServicesCommercial Services Grant Thornton LLP provides accounting, tax and business consulting services. It offers advisory, business consulting, business risk, enterprise technology and innovation, transaction services, data analytics, cyber risk, and data integrity services. The firm serves the construction, real estate and hospitality, consumer and industrial products, energy, financial services, health care and life sciences, not for profit organizations, private equity, public sector, and technology industries. The company was founded in 1924 and is headquartered in Chicago, IL. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of British Columbia | College/University | Doctorate Degree Doctorate Degree Masters Business Admin Graduate Degree Doctorate Degree | |
Simon Fraser University | College/University | Masters Business Admin Undergraduate Degree | |
Richard Ivey School of Business | College/University | Masters Business Admin Masters Business Admin | |
York University | College/University | Graduate Degree Undergraduate Degree | |
Merus Labs, Inc.
Merus Labs, Inc. Pharmaceuticals: MajorHealth Technology Part of Norgine Europe BV, Merus Labs, Inc. is a Canadian pharmaceutical company that manufactures pharmaceutical products. The company is based in Vancouver, Canada. The company was founded by Penny White, Ahmad Doroudian. Paul William Pay has been the CEO of the company since 2017. Merus Labs was acquired by Range Gold Corp. on March 26, 2010. | Pharmaceuticals: Major | Founder Director of Finance/CFO | |
Institute of Corporate Directors
Institute of Corporate Directors Miscellaneous Commercial ServicesCommercial Services The Institute of Corporate Directors is a not-for-profit, member-based association that serves as a resource and voice for directors and boards. The non-profit company is based in Toronto, Canada, and has subsidiaries in Canada. The ICD provides thought leadership through various publications and is a unified voice for directors. The Canadian company was founded by Brian J. Gibson, and Rahul K. Bhardwaj has been the CEO of the company since 2016. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
XENON PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
The University of Waterloo | College/University | Undergraduate Degree Graduate Degree | |
Aptus Health, Inc.
Aptus Health, Inc. Miscellaneous Commercial ServicesCommercial Services Aptus Health, Inc. operates a marketing platform for physicians and health care professionals. Its services include Geo-targeting mobile advertising; clinical alerts and eNewsletters; insight and attitudinal surveys; KOL-led presentations; eDetails; Peer-to-Peer collaboration; eSampling; Electronic Health Record integration; patient feedback; segmentation and tartgeting; behavioral insights; and intelligence and reporting. The company was founded by Donato J. Tramuto in 2008 and is headquartered in Reading, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Freiburg Medical School | College/University | Doctorate Degree | |
REDHILL BIOPHARMA LTD. | Pharmaceuticals: Major | Founder | |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ICON Clinical Research (Canada), Inc. | Corporate Officer/Principal | ||
Merz Pharmaceuticals GmbH
Merz Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Merz Pharmaceuticals GmbH discovers and develops drugs for the treatment of neurological and psychiatric diseases. Its dermatology products focus on the treatment of scars, acne, hair loss and fungal diseases. In the area of metabolic disturbances, it offers therapies for liver disease and lipid metabolism disorders. The company also offers various OTC products, including cold remedies, skin care products and vitamin supplements under the brand names tetesept and Merz Special. The company is headquartered in Frankfurt am Main, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
RELEVIUM TECHNOLOGIES INC. | Pharmaceuticals: Other | Chief Tech/Sci/R&D Officer | |
Association of Women In Finance
Association of Women In Finance Miscellaneous Commercial ServicesCommercial Services Association of Women In Finance operates as a non-profit organization. It provides a forum for networking and exchanging business knowledge, ideas and opinions. It supports advancement of women in finance. The organization consists of executives, bankers, lawyers, accountants, investment professionals, actuaries, venture capitalists, insurers and entrepreneurs working across public and private industries. The company was founded in 1996 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal | |
Interface Biologics, Inc.
Interface Biologics, Inc. Information Technology ServicesTechnology Services Interface Biologics, Inc. operates as a commercial stage privately held company that develops transformative biomedical polymer technologies to improve the safety and effectiveness of medical devices. It provides technologies to medical device manufacturers and drug companies. The company was founded by Paul J. Santerre in December 2001 and is headquartered in Toronto, Canada. | Information Technology Services | Corporate Officer/Principal | |
STRATEGIC MINERALS EUROPE CORP. | Other Metals/Minerals | Director/Board Member | |
Genome Research Ltd.
Genome Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of The Wellcome Trust Ltd., Genome Research Ltd. is a world-leading genomics research institute founded in 1992. The company is based in Cambridge, UK. Genome Research delivers therapeutic, diagnostic, and production benefits in areas such as cancer, immunology, public health, and personalized treatment. The British company tackle some of the most difficult challenges in genomic research, demanding science at scale and a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways. The company's work helps improve human health and understand life on a molecular level. | Miscellaneous Commercial Services | Director/Board Member | |
TRELLUS HEALTH PLC | Internet Software/Services | Chairman | |
The Bioindustry Association
The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Chairman |
Statistiques
Internationale
Canada | 20 |
Etats-Unis | 12 |
Allemagne | 5 |
Royaume-Uni | 5 |
Israël | 2 |
Sectorielle
Health Technology | 20 |
Commercial Services | 10 |
Consumer Services | 8 |
Technology Services | 3 |
Finance | 2 |
Opérationnelle
Director/Board Member | 170 |
Corporate Officer/Principal | 68 |
Independent Dir/Board Member | 55 |
Chief Executive Officer | 40 |
Chairman | 38 |
Relations les plus connectées
Insiders | |
---|---|
Robert Metcalfe | 51 |
Frank Holler | 29 |
Andrew Smith | 25 |
Mohammad Azab | 21 |
Wolfgang Renz | 17 |
Brett Whalen | 16 |
Daniel Mahony | 14 |
Ahmad Doroudian | 13 |
Yu Ying Liang | 13 |
Deborah Brown | 13 |
Douglas Lindsay Wu | 12 |
Moira Ong | 12 |
Rupert Williams | 11 |
James Parsons | 10 |
Hooshmand Sheshbaradaran | 10 |
- Bourse
- Insiders
- Steven Sangha
- Connexions Sociétés